Is Aikido Pharma Inc (AIKI) Stock Near the Top of the Biotechnology Industry?

Tuesday, July 28, 2020 2:55 PM | InvestorsObserver Analysts

A rating of 10 puts Aikido Pharma Inc (AIKI) near the bottom of the Biotechnology industry according to InvestorsObserver. Aikido Pharma Inc's score of 10 means it scores higher than 10% of stocks in the industry. Aikido Pharma Inc also received an overall rating of 22, putting it above 22% of all stocks. Biotechnology is ranked 14 out of the 148 industries.

Overall Score - 22
AIKI has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on AIKI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 22 would rank higher than 22 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aikido Pharma Inc Stock Today?

Aikido Pharma Inc (AIKI) stock is up 4.5% while the S&P 500 is down -0.03% as of 2:52 PM on Tuesday, Jul 28. AIKI has risen $0.05 from the previous closing price of $1.11 on volume of 1,791,638 shares. Over the past year the S&P 500 has risen 7.20% while AIKI is down -51.26%. AIKI lost -$2.31 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Share this article:

Related Companies

You May Also Like